This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Kazuhiro Kimura: Innovator in Thienopyrimidine Derivatives
Introduction
Kazuhiro Kimura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of chemistry, particularly in the production of thienopyrimidine derivatives. His work focuses on developing processes that enhance the efficiency and yield of these compounds, which have important applications in pharmaceuticals.
Latest Patents
Kazuhiro Kimura holds a patent for "Processes for the production of thienopyrimidine derivatives." This invention provides a method for producing an intermediate for thienopyrimidine derivatives that exhibit GnRH antagonistic activity on an industrial scale. The process involves a series of chemical reactions, including acid halogenation and treatment with malonic acid ester, which ultimately leads to high-yield production of the desired compounds.
Career Highlights
Kimura is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work there has been instrumental in advancing the production techniques for thienopyrimidine derivatives. With a focus on industrial scalability, his innovations contribute to the development of effective pharmaceutical solutions.
Collaborations
Kazuhiro Kimura has collaborated with notable colleagues such as Hiroaki Yamamoto and Koichiro Fukuoka. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.
Conclusion
Kazuhiro Kimura's contributions to the field of chemistry, particularly in the production of thienopyrimidine derivatives, highlight his innovative spirit and dedication to advancing pharmaceutical science. His work not only improves production methods but also paves the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
